Improving Access to Medicine: The Role of Pharma Companies in Emerging Markets
Access to medicines has persistent and systemic differences across the globe and within countries. The issue is addressed as part of the United Nations Sustainable Development Goals, with the objective to “provide access to medicines for all.” To achieve this aim, a multi-stakeholder approach is required, in which the pharmaceutical industry has a pivotal role to play.
Our Market Access experts have identified risks and opportunities associated with improving access to medicines in emerging countries and explored strategies that pharmaceutical companies can implement.
Learn more from the article “Improving Access to Medicine: The Role of Pharma Companies in Emerging Markets” published on PM360.
Our experts behind the article “Improving Access to Medicine: The Role of Pharma Companies in Emerging Markets”:
- Oscar Dumoulin, Global Market Access Consultant
- Aaron Grandy, Associate Director, Global Market Access
- Ahmad Bechara, Managing Partner, Global Pricing & Market Access